ஒற்றை செல் நோய் எதிர்ப்பு சக்தி ப்ரோஃபைலிஂக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஒற்றை செல் நோய் எதிர்ப்பு சக்தி ப்ரோஃபைலிஂக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஒற்றை செல் நோய் எதிர்ப்பு சக்தி ப்ரோஃபைலிஂக் Today - Breaking & Trending Today

ROSALIND, HELiXrUS and Geninus Partner to Bring Powerful New Single Cell Analysis Services to Cancer Researchers


Press release content from Business Wire. The AP news staff was not involved in its creation.
ROSALIND, HELiXrUS and Geninus Partner to Bring Powerful New Single Cell Analysis Services to Cancer Researchers
April 15, 2021 GMT
SAN DIEGO & SEOUL, South Korea (BUSINESS WIRE) Apr 15, 2021
ROSALIND ®, a software leader in extracting meaningful insights from diverse pools of life science data, today announced that it has partnered with two Seoul-based technology providers to enable a powerful new Single Cell data analysis solution for cancer research scientists in Asia. Geninus, a leading full-service genomics laboratory, will combine the ROSALIND platform with its Celinus™ single cell RNA sequencing service to enable expanded analysis and interpretation of data, as well as seamless sharing and collaboration across labs and geographies. HELiXrUS, a channel partnership company focused on biological big data and multi-omics, played a leading role in establishing this p ....

Soult Ukpyolsi , South Korea , United States , San Diego , Tim Wesselman , Colin Sanford , Geninu Celinus , Samsung Genome Institute , Helixrus Inc , Single Cell , Single Cell Analysis , Genome Biology , Single Cell Gene Expression , Single Cell Immune Profiling , Single Nucleus Gene Expression , Single Cell Multiome , Spatial Gene Expression , Cell Solution , Woong Yang Park , Business Wire , Products And Services , Scientific Research , Pharmaceutical Manufacturing , Health Care Industry , Data Management , New Products And Services ,

Immunai Joins 10x To Scale Single Cell Genomics


Immunai Joins 10x To Scale Single Cell Genomics
December 21, 2020
By Allison Proffitt 
December 21, 2020 | Immunai has announced its collaboration with 10x Genomics as one of the first 10x Certified Service Providers. Immunai will leverage 10x’s robust single-cell technologies to map hundreds of cell types and states. By applying its proprietary artificial intelligence and machine learning algorithms, Immunai supports biomarker discovery and insight generation to ultimately power new therapeutic discoveries and accelerate drug development. 
Immunai was started by Luis Voloch and Noam Solomon about two years, Voloch told
Bio-IT World. The goal is to “revolutionize immunology” by scaling single cell genomics, he said, both in the lab and computationally.   ....

New York , United States , San Francisco , Tel Aviv , Brad Crutchfield , Allison Proffitt , Sloan Kettering , Luis Voloch , Certified Service Providers , Certified Service Provider Program , Baylor College Of Medicine , Certified Service , Noam Solomon , Human Cell Atlas , Memorial Sloan Kettering , Massachusetts General Hospital , Baylor College , Single Cell Immune Profiling , Chief Commercial Officer , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , சான் பிரான்சிஸ்கோ , தொலைபேசி அவிவ் , பிராட் கிருச்சபையில்ட் , அல்லிசன் ப்ரோப்பிட்ட் , ஸ்லோன் கெட்டரிங் ,